Watch Demo

Belgium Antidiabetics Industry Outlook 2024 - 2028

See how Belgium Antidiabetics performed compared to key markets.

Key Market Indicators

Belgium's insulin import market is projected to reach nearly $190 million by 2028, up from approximately $164 million in 2023, reflecting an annual growth rate of 2.2%. Since 2004, the demand for insulin in Belgium has grown steadily, with a yearly increase of 3%. On the export front, Belgian insulin exports are expected to climb to about $90 million by 2028, compared to $75 million in 2023, marking an average annual growth rate of 2.8%. Since 2004, the country's insulin supply has increased by 4.4% each year. In 2023, Belgium ranked eighth in global insulin exports, with Hungary narrowly ahead at around $75 million. Leading the rankings were France, Italy, and China, occupying the second, third, and fourth positions, respectively.

Marketing Banner

Belgium Antidiabetics Market Data and Forecasts

How much will Belgium Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in Belgium
Forecast: Import of Insulin in Dosage Forms to Belgium
Forecast: Export of Insulin in Dosage Forms from Belgium
Forecast: Import of Insulin to Belgium
Forecast: Export of Insulin from Belgium
More in Antidiabetics Industry for 2028